Abstract
Background
The laparoscopic and open approaches have comparable safety and oncological efficacy to treat early (T1b or T2) stage incidental gallbladder cancer (IGBC). However, their effects on T3 stage or above tumors unclear.
Methods
Data of IGBC patients who underwent radical re-resection were retrospectively analyzed. Demographic characteristics, surgical variables, and tumor characteristics were evaluated for association with survival.
Results
We analyzed retrospectively 201 patients (72 men, 129 women; median age 63 years; range, 36–85 years). 84 underwent laparoscopic re-resection and 117 underwent open surgery. The 5-year OS post-resection was 74.7%, with a median survival of 74.52 months. The median OS (73.92 months vs. 77.04 months, P = 0.67), and disease-free survival (72.60 months vs. 71.09 months, P = 0.18) were comparable between the laparoscopic re-resection and open surgery groups. The survival of patients with T1/T2 (median: 85.50 months vs. 80.14 months; P = 0.67) and T3 (median: 68.56 months vs. 58.85 months; P = 0.36) disease were comparable between the open re-resection and laparoscopic re-resection groups even after PS matching. Open surgery group lost significantly more blood, while laparoscopic surgery took longer. The postsurgical stay in the laparoscopic re-resection group was significantly shorter. Combined extrahepatic bile duct resection, gallbladder perforation, pT, pStage, histological grade, microscopic liver invasion, status of the resected margin, and adjuvant therapy comprised significant independent prognostic indicators for IGBC.
Conclusions
Laparoscopic and open surgery can achieve similar short and long-term outcomes for T3 IGBC; however, careful surgical manipulation is necessary to avoid secondary injuries.
Graphical abstract
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are not publicly available due to institutional policy but are available from the corresponding author on reasonable request.
References
Lau CSM, Zywot A, Mahendraraj K, Chamberlain RS (2017) Gallbladder carcinoma in the United States: a population based clinical outcomes study involving 22,343 patients from the surveillance, epidemiology, and end result database (1973–2013). HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 2017:1532835
Lundgren L, Muszynska C, Ros A, Persson G, Gimm O, Valter L, Andersson B, Sandström P (2018) Are incidental gallbladder cancers missed with a selective approach of gallbladder histology at cholecystectomy? World J Surg 42:1092–1099
Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D’Angelica M, Dematteo RP, Blumgart LH, O’Reilly EM (2008) Gallbladder cancer (GBC): 10-year experience at memorial sloan-kettering cancer centre (MSKCC). J Surg Oncol 98:485–489
Pitt SC, Jin LX, Hall BL, Strasberg SM, Pitt HA (2014) Incidental gallbladder cancer at cholecystectomy: when should the surgeon be suspicious? Ann Surg 260:128–133
Neuhaus SJ, Texler M, Hewett PJ, Watson DI (1998) Port-site metastases following laparoscopic surgery. Br J Surg 85:735–741
Drouard F, Delamarre J, Capron JP (1991) Cutaneous seeding of gallbladder cancer after laparoscopic cholecystectomy. N Engl J Med 325:1316
Fornara P, Zacharias M, Wagner S (2003) Port-site metastases: fact or fiction? Urol Int 71:136–142
Aloia TA, Jarufe N, Javle M, Maithel SK, Roa JC, Adsay V, Coimbra FJ, Jarnagin WR (2015) Gallbladder cancer: expert consensus statement. HPB (Oxford) 17:681–690
Kang CM, Choi GH, Park SH, Kim KS, Choi JS, Lee WJ, Kim BR (2007) Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma. Surg Endosc 21:1582–1587
Gumbs AA, Jarufe N, Gayet B (2013) Minimally invasive approaches to extrapancreatic cholangiocarcinoma. Surg Endosc 27:406–414
Köhn N, Maubach J, Warschkow R, Tsai C, Nussbaum DP, Candinas D, Gloor B, Schmied BM, Blazer DG 3rd, Worni M (2018) High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis. HPB (Oxford) 20:1073–1081
Gani F, Buettner S, Margonis GA, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM (2016) Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer. J Surg Oncol 114:176–180
Jang JY, Han HS, Yoon YS, Cho JY, Choi Y (2019) Retrospective comparison of outcomes of laparoscopic and open surgery for T2 gallbladder cancer–thirteen-year experience. Surg Oncol 29:142–147
Shirobe T, Maruyama S (2015) Laparoscopic radical cholecystectomy with lymph node dissection for gallbladder carcinoma. Surg Endosc 29:2244–2250
Itano O, Oshima G, Minagawa T, Shinoda M, Kitago M, Abe Y, Hibi T, Yagi H, Ikoma N, Aiko S, Kawaida M, Masugi Y, Kameyama K, Sakamoto M, Kitagawa Y (2015) Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma. Surg Endosc 29:3600–3607
de Aretxabala X, Oppliger F, Solano N, Rencoret G, Vivanco M, Carvajal D, Hepp J, Roa I (2018) Laparoscopic management of incidental gallbladder cancer. Surg Endosc 32:4251–4255
Yoon YS, Han HS, Cho JY, Choi Y, Lee W, Jang JY, Choi H (2015) Is laparoscopy contraindicated for gallbladder cancer? a 10-year prospective cohort study. J Am Coll Surg 221:847–853
Vega EA, De Aretxabala X, Qiao W, Newhook TE, Okuno M, Castillo F, Sanhueza M, Diaz C, Cavada G, Jarufe N, Munoz C, Rencoret G, Vivanco M, Joechle K, Tzeng CD, Vauthey JN, Vinuela E, Conrad C (2020) Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg 107:289–300
Søreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ (2019) Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg 106:32–45
Matsuyama R, Yabusita Y, Homma Y, Kumamoto T, Endo I (2021) Essential updates 2019/2020: Surgical treatment of gallbladder cancer. Ann Gastroenterol Surg 5:152–161
Amin MBES, Greene F, Byrd DR, Brookland RK, Washington MK, AJCC, American Cancer Society et al (2017) Gallbladder AJCC Cancer Staging Manual, 8th edn. Springer International, New York
Aloia TA, Zorzi D, Abdalla EK, Vauthey JN (2005) Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 242:172–177
Palavecino M, Kishi Y, Chun YS, Brown DL, Gottumukkala VN, Lichtiger B, Curley SA, Abdalla EK, Vauthey JN (2010) Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery 147:40–48
Jin Y, Gao W, Regmi P, Hu H, Cheng N, Li F (2022) Oncologic extended resection of T3-stage incidental gallbladder carcinoma. J Gastrointest Surg 26(4):991–992
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196
Lundgren L, Muszynska C, Ros A, Persson G, Gimm O, Andersson B, Sandström P (2019) Management of incidental gallbladder cancer in a national cohort. Br J Surg 106:1216–1227
Park JH, Kim YH, Kim H, Yoon YS, Choi YR, Cho JY, Lee YJ, Han HS (2016) Determining the extent of cholecystectomy using intraoperative specimen ultrasonography in patients with suspected early gallbladder cancer. Surg Endosc 30:4229–4238
Birnbaum DJ, Viganò L, Russolillo N, Langella S, Ferrero A, Capussotti L (2015) Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio. Ann Surg Oncol 22:811–818
Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Mitsuhashi N, Takeuchi D, Suda K, Yoshioka I, Miyazaki M (2007) Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese society of biliary surgery classification. J Hepatobiliary Pancreat Surg 14:358–365
Papageorge MV, de Geus SWL, Woods AP, Ng SC, Drake FT, Cassidy MR, McAneny DB, Tseng JF, Sachs TE (2021) Undertreatment of gallbladder cancer: a nationwide analysis. Ann Surg Oncol 28:2949–2957
Adsay NV, Basturk O, Altinel D, Khanani F, Coban I, Weaver DW, Kooby DA, Sarmiento JM, Staley C (2009) The number of lymph nodes identified in a simple pancreatoduodenectomy specimen comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol 22:107–112
DeCoste R, McDonell LM, Uzans D, Molinari M, Huang WY (2020) Comparing pathology report quality indicators in 2 distinct whipple resection specimen protocols. Pancreas 49:788–792
Obara H, Kentaro M, Inoue M, Kitagawa Y (2020) Current management strategies for visceral artery aneurysms: an overview. Surg Today 50:38–49
Watanabe Y, Kurashima Y, Madani A, Feldman LS, Ishida M, Oshita A, Naitoh T, Noma K, Yasumasa K, Nagata H, Nakamura F, Ono K, Suzuki Y, Matsuhashi N, Shichinohe T, Hirano S (2016) Surgeons have knowledge gaps in the safe use of energy devices: a multicenter cross-sectional study. Surg Endosc 30:588–592
Acknowledgements
We would like to thank Elixigen (www.elixigen.com.cn) for English language editing.
Funding
This work was supported by the Young Scientists Fund of National Natural Science Foundation of China (82203650), Sichuan Science and Technology Program (2021YJ0132), Science and Technology Bureau of Sichuan Province (2020YFS0099), Natural Science Foundation of Sichuan Province (2022NSFSC0806), 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYJC18014, ZYJC21046), 1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University (2021HXFH001), and Sichuan University-Zigong School-local Cooperation project (2021CDZG-23).
Author information
Authors and Affiliations
Contributions
Y-WJ and W-JM contributed equally to the study. Y-WJ and W-JM performed the majority of manuscript. WG provided the collection of all the material and were also involved in editing the manuscript. N-SC and F-YL revised the manuscript critically and gave the final approval of the version to be published.
Corresponding authors
Ethics declarations
Disclosures
Yan-Wen Jin, Wen-Jie Ma, Wei Gao, Fu-Yu Li, Nan-Sheng Cheng have no conflicts of interest or financial ties to disclose.
Ethical approval
This study was performed in accordance with the Declaration of Helsinki, and it complied with the study protocol and the Ethical Guidelines for Medical and Health Research Involving Human Subjects. This study was approved by the institutional review committee of West China Hospital, Sichuan University (approval code 2021–445). The protocol summary was described on the hospital website.
Informed consent
Since this was a retrospective study, the requirement for informed consent was waived by ethics committee of West China Hospital, Sichuan University.
Consent for publication
All authors have read and approved this manuscript. All authors consent to the publication of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
464_2022_9839_MOESM2_ESM.eps
Supplementary file2 (EPS 170 kb) Related to Figure 4. Overall survival for sixty-three T2 and thirty-six T3 patients with IGBC treated with laparoscopic and open approaches after PS matching.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jin, YW., Ma, WJ., Gao, W. et al. Laparoscopic versus open oncological extended re-resection for incidental gallbladder adenocarcinoma: we can do more than T1/2. Surg Endosc 37, 3642–3656 (2023). https://doi.org/10.1007/s00464-022-09839-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-022-09839-x